Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4,6-dideoxy-4-{[4-[(4-O-hexopyranosylhexopyranosyl)oxy]-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}hexopyranosyl-(1->4)hexopyranosyl-(1->4)hexopyranose
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic carbohydrate derivative with the molecular formula C37H63NO28 and a molecular weight of approximately 969.9 g/mol. It is structurally related to aminoglycosides and contains multiple hexose (sugar) units linked via glycosidic bonds to a cyclohexene core. The molecule is classified as an experimental small molecule and has not been approved for clinical use or assigned any therapeutic indication. Its mechanism of action has not been characterized in the literature or major drug databases. There are no known clinical trials or regulatory approvals associated with this compound[2][3][7].
- Other names
- 4,6-Dideoxy-4-{[(1S,4R,5R,6S)-4-{[alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl]oxy}-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-Yl]amino}-alpha-D-glucopyranose4,6-dideoxy-4-{[(1S,4R,5R,6S)-4-{[O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl]oxy}-5,6-dihydroxy-cyclohexen-Yl]amino}-glucopyranose
Beyond the preview
Go deeper on 4,6-dideoxy-4-{[4-[(4-O-hexopyranosylhexopyranosyl)oxy]-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}hexopyranosyl-(1->4)hexopyranosyl-(1->4)hexopyranose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4,6-dideoxy-4-{[4-[(4-O-hexopyranosylhexopyranosyl)oxy]-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}hexopyranosyl-(1->4)hexopyranosyl-(1->4)hexopyranose.